Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells
Authors:
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (8) , 2680-2686
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- VEGF blockade inhibits angiogenesis and reepithelialization of endometriumThe FASEB Journal, 2008
- Endometrial structural and inflammatory changes with exogenous progestogensTrends in Endocrinology & Metabolism, 2008
- A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1Circulation Research, 2008
- Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester DeciduaThe American Journal of Pathology, 2007
- Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cellsBritish Journal of Cancer, 2005
- Recent advances in endometrial angiogenesis researchAngiogenesis, 2005
- Endometrial Angiogenesis: From Physiology to PathologyAnnals of the New York Academy of Sciences, 2004
- Steroid hormone regulation of angiogenesis in the primate endometriumFrontiers in Bioscience-Landmark, 2003
- Pharmacokinetics of Selective Estrogen Receptor ModulatorsClinical Pharmacokinetics, 2003
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997